Louise Bannon: Thomas Reiser to Step Down as ISTH Executive Director
Louise Bannon, Director of Membership, Marketing and External Relations of ISTH, reposted from International Society on Thrombosis and Haemostasis on LinkedIn:
”Today, the International Society on Thrombosis and Haemostasis (ISTH) shared that Thomas Reiser will step down as Executive Director at the end of 2025.
Tom has led the Society with dedication and strategic vision for more than 14 years, and we are deeply grateful for his tremendous service, mentorship and commitment to strengthening our global community. We look forward to continuing to work closely with him through the remainder of the year as we prepare for this transition.
I am honored to step into the role of Interim Executive Director on January 1 and it is a privilege to serve our members, partners and the global thrombosis and hemostasis community during this important chapter for the Society.
Our mission remains clear and our momentum strong. In the months ahead, I look forward to partnering with our exceptional staff, volunteer leaders and valued stakeholders to continue advancing science, education and advocacy for the benefit of patients worldwide.
To all who support our work, especially our talented staff, thank you. Your dedication and heart power everything we do. I feel fortunate to work alongside you and look forward to continuing our important work together in the months ahead.”
Quoting International Society on Thrombosis and Haemostasis‘s post:
”The ISTH announces that Thomas Reiser will step down from his position as Executive Director, following a commendable 14-year period of leadership at the Society. As part of a carefully planned transition, the ISTH Council appoints Louise St. Germain, ISTH Director of Membership, Marketing and External Relations, to the role of Interim Executive Director effective on January 1, 2026. As the search for a permanent Executive Director commences, the ISTH looks forward to the opportunities ahead and to the Society continuing to evolve, innovate and strengthen its impact for the benefit of the global thrombosis and hemostasis community.
Read more.”
Stay updated with Hemostasis Today.
-
May 26, 2026, 13:21Isabelle Mahé: Frailty Does Not Mean Less Anticoagulation
-
May 26, 2026, 12:32Behçet Syndrome and Thrombosis: When Inflammation Becomes a Clot
-
May 26, 2026, 12:29Priya Prasad: When Blood Becomes the Battlefield – Transfusion Medicine Saves Lives
-
May 26, 2026, 12:21Mavis Agnes Kisakye: Uganda at the WFH Regional Conference on Blood Disorders
-
May 26, 2026, 12:19Megan Adediran: Giving Hope to People Living with Bleeding Disorders
-
May 26, 2026, 11:36Abid Ur Rahman: Understanding the Coagulation Cascade and Hemostasis
-
May 26, 2026, 11:35Isaac Okello: The Real Sickle Cell Crisis Is Not Only the Disease Itself
-
May 26, 2026, 11:34Ziad Omar: PTT and aPTT Testing – Reading the Intristic Pathway of Coagulation
-
May 26, 2026, 11:33Megan Griffiths: Advancing the Understanding of Risk and Outcomes in Pulmonary Hypertension